Stockreport
Here's What Analysts Are Saying About Vertex Pharmaceuticals (VRTX) [Yahoo! Finance]
Last vertex pharmaceuticals incorporated earnings: 4/29 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations: investors.vrtx.com
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX ) is one of the top gene therapy stocks to buy according to hedge funds . Canaccord lifted the price target on Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) to $441 from $411 on February 17 and maintained a Hold rating on the shares, telling investors that it updated its model after the fiscal Q4 results delivered the familiar top and bottom line beat. The firm also stated that Trikafta revenue came in slightly below consensus and Alyftrek slightly above. The same day, Barclays also adjusted the price target on Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) to $607 from $606 and maintained an Overweight rating on the shares after the fiscal Q4 report. Is Vertex Pharmaceuticals Incorporated (VRTX) the Best Stock to Buy According to Jim Simons' Renaissance Technologies? In another development, H.C. Wainwright lifted the price target on Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) to $591 from $518 on February 17, reaffir
[Read more]
| IMPACT SNAPSHOT | EVENT TIME: | VRTX | ||||
|---|---|---|---|---|---|---|
|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| LAST PRICE | ||
| VWAP | ||
|
High:
|
MAX UP |
High:
|
|
Low:
|
MAX DOWN |
Low:
|
|
%
|
POST NEWS RANGE |
%
|
|
|
PRICE CHANGE |
|
|
|
PRICE CHANGE PERCENTAGE |
|
|
|
S&P 500 (SPX) |
|
|
%
|
VOLUME RATIO |
%
|
| VOLUME (SHARES) | ||
| TICKS | ||
|
|
AVG SHARES PER TRADE |
|
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Be the first to know
Opt in for alerts from News Quantifed
Opt-in for
VRTX alerts
VRTX alerts
from News Quantified
Movers & Shakers
The biggest gainers and losers and WHY it moved
VRTX alerts
High impacting Vertex Pharmaceuticals Incorporated news events
Weekly update
A roundup of the hottest topics
VRTX
NEWS
NEWS
- Three decades into cystic fibrosis fight, Boomer Esiason and his son Gunnar are winning [CNBC][CNBC]
- Vertex Gets Rating Upgrade, Earnings Rose Every Quarter This Past Year [Yahoo! Finance][Yahoo! Finance]
- Crispr Therapeutics gains amid takeover speculation [Seeking Alpha][Seeking Alpha]
- Is Vertex Stock Outperforming the Dow? [Yahoo! Finance][Yahoo! Finance]
- TIME Reveals 2026 Women of the Year List Recognizing 16 Leaders Working Toward a More Equitable World [Yahoo! Finance][Yahoo! Finance]
- More
VRTX
SEC Filings
SEC Filings
- 3/4/26 - Form 4
- 3/4/26 - Form 144
- 3/3/26 - Form 3
- VRTX's page on the SEC website
- More